Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
Disease problems in shrimp production are poorly understood and diagnosed. Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge. Diagnosis of that disease is very important. There is no therapeutic option available for viral diseases and the only option available to detect and avoid the pathogen entry into culture systems. DNA based diagnostic tool such as PCR used to test. Diagnosis tools and technologies are gaining demand for the quick and effective diagnosis of shrimp diseases for management of disease outbreaks. Assay based kits and rapid test kits are available for the shrimp\'s disease diagnostic market.
In 2018, the global Shrimps Disease Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Shrimps Disease Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Shrimps Disease Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
GeneReach Biotechnology Corp
pop bio
SUREBIO
Auro Biotechnologies
Market segment by Type, the product can be split into
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Market Segment by Application, split into
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America